Autopsy report · NCT00773084

Aliskiren and Renin Inhibition in Diastolic Heart Failure

“Difficulty in recruiting patients and then the PI left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Texas Tech University Health Sciences Center

Sponsor type

University, hospital or other

Conditions

Diastolic Heart Failure

Interventions

Aliskiren plus spironolactone vs. Lisinopril plus spironolactone

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
  “PI left institution, end of funding, clinic relocation, recruitment issues” (78% match in meaning)
• Does Thiamine Help Vomiting and Nausea in Pregnancy?
  “Difficulties in recruiting patients” (75% match in meaning)
• Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
  “Difficulties surrounding recruiting patients” (75% match in meaning)
• Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
  “Unable to recruit sufficient participants due to lack of funding; PI has left the institution.” (75% match in meaning)
• Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
  “Difficulty in recruiting patients” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.